416 related articles for article (PubMed ID: 32244213)
21. Atypical pituitary adenoma: a clinicopathologic case series.
Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
[TBL] [Abstract][Full Text] [Related]
22. MEN 1 and 2: the role of diagnostic imaging.
Gollini P; Cataldi A; Fava C
Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
[TBL] [Abstract][Full Text] [Related]
23. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
24. Difference in the incidence of cerebrospinal fluid leakage and residual tumors between functional and nonfunctional pituitary adenomas treated by endoscopic transsphenoidal pituitary adenomectomy.
Lee CY; Chen YC; Wang YP; Chen SJ
J Int Med Res; 2019 Nov; 47(11):5660-5670. PubMed ID: 31558077
[TBL] [Abstract][Full Text] [Related]
25. The Value of Intraoperative Magnetic Resonance Imaging in Endoscopic and Microsurgical Transsphenoidal Pituitary Adenoma Resection.
Pal'a A; Knoll A; Brand C; Etzrodt-Walter G; Coburger J; Wirtz CR; Hlaváč M
World Neurosurg; 2017 Jun; 102():144-150. PubMed ID: 28286276
[TBL] [Abstract][Full Text] [Related]
26. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
27. Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery.
Alhilali LM; Little AS; Yuen KCJ; Lee J; Ho TK; Fakhran S; White WL
J Neurosurg; 2020 Feb; 134(3):761-770. PubMed ID: 32032952
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG).
de Laat JM; Dekkers OM; Pieterman CR; Kluijfhout WP; Hermus AR; Pereira AM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; de Herder WW; Valk GD
J Clin Endocrinol Metab; 2015 Sep; 100(9):3288-96. PubMed ID: 26126205
[TBL] [Abstract][Full Text] [Related]
30. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging.
Lee JYK; Cho SS; Zeh R; Pierce JT; Martinez-Lage M; Adappa ND; Palmer JN; Newman JG; Learned KO; White C; Kharlip J; Snyder P; Low PS; Singhal S; Grady MS
J Neurosurg; 2018 Aug; 129(2):390-403. PubMed ID: 28841122
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Endoscopic Transsphenoidal Approach for More Aggressive Pediatric Pituitary Adenomas: Early- and Late-Term Results from a Single Center Experience.
Caklili M; Yilmaz E; Duman Ozturk S; Uzuner A; Yildirim P; Cizmecioglu Jones FM; Tas A; Cabuk B; Anik I; Ceylan S
World Neurosurg; 2023 Aug; 176():e623-e633. PubMed ID: 37271260
[TBL] [Abstract][Full Text] [Related]
32. Comparative preoperative characteristics and postoperative outcomes at a private versus a safety-net hospital following endoscopic endonasal transsphenoidal resection of pituitary adenomas.
Cyprich J; Pangal DJ; Rutkowski M; Donoho DA; Shiroishi M; Jason Liu CS; Carmichael JD; Zada G
J Neurosurg; 2020 Feb; 134(3):742-749. PubMed ID: 32109866
[TBL] [Abstract][Full Text] [Related]
33. Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution.
D'Haens J; Van Rompaey K; Stadnik T; Haentjens P; Poppe K; Velkeniers B
Surg Neurol; 2009 Oct; 72(4):336-40. PubMed ID: 19604551
[TBL] [Abstract][Full Text] [Related]
34. Various Strategies of Transsphenoidal Pseudocapsule-Based Extracapsular Resection in Noninvasive Functional Pituitary Adenomas and their Effectiveness and Safety.
Li QX; Wang WH; Wang XX
Neurol India; 2019; 67(6):1448-1455. PubMed ID: 31857533
[TBL] [Abstract][Full Text] [Related]
35. Significance and Indications of Surgery for Asymptomatic Nonfunctioning Pituitary Adenomas.
Ogiwara T; Nagm A; Nakamura T; Mbadugha T; Horiuchi T; Hongo K
World Neurosurg; 2019 Aug; 128():e752-e759. PubMed ID: 31077893
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
37. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT
Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series.
Cavallo LM; Solari D; Tasiou A; Esposito F; de Angelis M; D'Enza AI; Cappabianca P
World Neurosurg; 2013; 80(3-4):342-50. PubMed ID: 23046913
[TBL] [Abstract][Full Text] [Related]
39. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
[TBL] [Abstract][Full Text] [Related]
40. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
